Blood glucose methods all report the same analyte, but their enzyme systems are not interchangeable. Glucose oxidase, several glucose dehydrogenase families, and the hexokinase–glucose-6-phosphate dehydrogenase system recognize glucose through different cofactors and electron-acceptor pathways. These differences determine whether a method is suited to a central laboratory analyzer, a colorimetric reagent, a disposable electrochemical strip, or another biosensor format.
The common abbreviation GOD is often used for glucose oxidase; GOx is also widely used. The term GDH is broader and can refer to NAD(P)-dependent, FAD-dependent, PQQ-dependent, or other acceptor-linked glucose dehydrogenases. A product should therefore be identified by its actual cofactor and reaction architecture rather than by “GDH” alone.
Our product offerings: Diabetes and Blood Glucose Testing Enzymes
| System | Primary Reaction Principle | Common Detection Context | Main Design Questions |
|---|---|---|---|
| Glucose oxidase (GOD/GOx) | Oxidizes beta-D-glucose using molecular oxygen and produces hydrogen peroxide | Peroxide-dependent colorimetry, oxygen electrodes, and selected electrochemical sensors | Oxygen dependence, peroxide chemistry, reducing interferents, anomer conversion |
| FAD-dependent GDH | Transfers electrons from glucose through FAD to an artificial acceptor or mediator | Electrochemical strips and biosensors | Mediator compatibility, substrate specificity, electron transfer, residual oxygen response |
| PQQ-dependent GDH | Uses pyrroloquinoline quinone and transfers electrons to an acceptor | Historically used in some electrochemical glucose systems | Cross-reactivity with non-glucose sugars must be characterized for the specific enzyme and device |
| NAD(P)-dependent GDH | Reduces NAD+ or NADP+ while oxidizing glucose | Photometric and biochemical assays | Cofactor choice, background cofactor conversion, optical range, specificity |
| Hexokinase–G6PDH | Phosphorylates glucose with ATP, then generates NAD(P)H from glucose-6-phosphate | Automated laboratory clinical chemistry | ATP and magnesium requirements, two-enzyme balance, UV absorbance, sample blank |
Glucose oxidase catalyzes the oxidation of beta-D-glucose to glucono-delta-lactone while oxygen is reduced to hydrogen peroxide. The lactone subsequently hydrolyzes to gluconic acid. In colorimetric methods, peroxidase uses the generated hydrogen peroxide to oxidize reporter substrates and form a measurable product. The final analytical response therefore depends on glucose oxidase, oxygen availability, peroxidase activity, chromogen chemistry, and the behavior of reducing substances in the specimen.
GOx has a long history in glucose measurement because it can provide strong glucose recognition and convenient peroxide generation. Its oxygen requirement, however, creates a second substrate whose concentration may vary with specimen, reaction geometry, membrane transport, and device design. Increasing enzyme loading does not automatically eliminate an oxygen-limited response.
FAD-dependent glucose dehydrogenases generally transfer electrons from glucose through a flavin cofactor to an artificial electron acceptor rather than relying on oxygen as the primary analytical acceptor. This makes them attractive for electrochemical test strips and biosensors. The practical signal depends on the complete electron-transfer chain: enzyme, mediator, electrode, membrane, applied potential, and sample transport.
FAD-GDH should not be assumed to be completely insensitive to oxygen or universally specific for glucose. Enzymes from different sources can differ in substrate range, electron-acceptor preference, thermal behavior, and suitability for immobilization. Candidate products should be tested against relevant sugars and under the actual sensor architecture.
PQQ-dependent glucose dehydrogenase illustrates why an enzyme family name is not enough to establish safety or analytical specificity. Some PQQ-GDH-based systems have shown clinically important responses to sugars other than glucose, including maltose in certain device contexts. FDA has emphasized the need to evaluate and communicate interference risks for blood glucose monitoring systems. The risk belongs to the specific enzyme-device combination and its intended-use population, not to a shorthand label alone.
Developers should use a cross-reactivity panel informed by the intended setting, medications, therapies, and plausible specimen components. Results should be expressed as assay bias across relevant glucose and interferent concentrations rather than only as relative activity in buffer.
NAD- or NADP-dependent GDH produces a nicotinamide-cofactor signal that can be monitored photometrically. These enzymes can support laboratory and biochemical formats but require careful control of cofactor purity, endogenous or contaminating cofactor-dependent activities, absorbance range, and blank drift.
The hexokinase method uses a two-step pathway. Hexokinase phosphorylates glucose with ATP, normally in the presence of magnesium. Glucose-6-phosphate dehydrogenase then oxidizes glucose-6-phosphate while reducing NAD+ or NADP+. The increase in absorbance from NADH or NADPH is related to glucose concentration. Because both reactions must proceed appropriately, ATP, magnesium, cofactor, enzyme balance, and timing are part of the measurement procedure.
Hexokinase systems are well suited to automated clinical chemistry but are not simply a more complex version of a glucose strip. They use a liquid UV-photometric architecture and impose different requirements from dry electrochemical devices.
D-glucose exists as alpha and beta anomers in aqueous solution. Some glucose-recognition enzymes prefer one anomer. Spontaneous mutarotation restores equilibrium, but early reaction kinetics can still depend on anomer distribution, reaction time, pH, and temperature. Mutarotase may be used in some designs to accelerate equilibration. Whether it is necessary should be established experimentally rather than assumed from the endpoint principle.
Whole blood is not a simple aqueous glucose solution. Red cells change plasma fraction, viscosity, diffusion, and electrochemical transport. Hematocrit can influence sample filling and the relationship between glucose concentration in plasma water and the measured response. Oxygen tension, temperature, humidity, sample volume, and user technique may also affect a strip-based system.
FDA's 2020 guidance for prescription point-of-care blood glucose monitoring systems describes performance studies and information recommended for premarket submissions. It addresses the complete device rather than certifying an isolated enzyme. Developers should distinguish prescription POCT systems from over-the-counter self-monitoring devices because intended users, study designs, and applicable guidance may differ.
| Risk | Most Relevant Architectures | Why It Occurs | Useful Evaluation |
|---|---|---|---|
| Oxygen response | GOx and some acceptor-linked systems | Oxygen competes in or limits electron transfer | Test the intended oxygen range at low, middle, and high glucose. |
| Alternate sugars | Selected GDH preparations | The active site may accept structurally related carbohydrates | Measure finished-device bias with relevant sugars and therapies. |
| Hematocrit | Whole-blood strips | Changes plasma volume fraction, viscosity, diffusion, and electrode access | Use a factorial study across hematocrit and glucose ranges. |
| Electroactive substances | Electrochemical sensors | Compounds may oxidize or reduce at the working potential | Challenge the complete electrode and mediator system. |
| Reducing substances | Peroxide colorimetry | Interferents may consume peroxide or reduce the reporter product | Evaluate reagent blanks and concentration-dependent recovery. |
| Post-collection glycolysis | Laboratory blood specimens | Cells continue consuming glucose before separation or stabilization | Validate collection tube, processing time, storage, and separation. |
Hexokinase–G6PDH and GOx–peroxidase methods are common starting points. Compare wavelength availability, reagent blank, sample index response, calibration stability, onboard stability, measuring range, and analyzer timing. The preferred route is the one that meets the complete performance specification, not necessarily the one with the shortest reaction scheme.
FAD-GDH, appropriate PQQ-GDH preparations, and GOx may be considered depending on the device. Selection must include mediator potential, electrode chemistry, printing and drying, membrane transport, fill detection, hematocrit, alternate sugars, oxygen, humidity, and strip-lot calibration.
Longer operational periods add biofouling, enzyme leaching, inflammatory encapsulation, mediator retention, signal drift, and calibration stability. An enzyme selected for a single-use strip may not be suitable for continuous operation even when its initial activity is high.
